Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Key facts

Sponsor

National Cancer Institute (NCI)

Principal Investigator

Mostafa Atri

NRG Oncology

Intervention

fludeoxyglucose F 18(radiation)

Enrollment

384 enrolled

Eligibility

18 years · FEMALE

Timeline

2007 – 2016

Study locations (30)

• Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
• University of California at Los Angeles Health System, Los Angeles, California, United States
• Olive View-University of California Los Angeles Medical Center, Sylmar, California, United States
• The Hospital of Central Connecticut, New Britain, Connecticut, United States
• Sarasota Memorial Hospital, Sarasota, Florida, United States
• Georgia Regents University Medical Center, Augusta, Georgia, United States
• Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
• Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States
• Mayo Clinic, Rochester, Minnesota, United States
• UMDNJ - New Jersey Medical School, Newark, New Jersey, United States
• Island Gynecologic Oncology, Brightwaters, New York, United States
• Mount Sinai Medical Center, New York, New York, United States
• Weill Medical College of Cornell University, New York, New York, United States
• Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States
• Carolinas Medical Center, Charlotte, North Carolina, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

NRG Oncology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Adenocarcinoma of the cervix uteri

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07276360
  Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
  Uganda Cancer Institute
• RECRUITINGPHASE1NCT07454642
  AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
  Avacta Life Sciences Ltd
• RECRUITINGPHASE3NCT07061977
  Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
  National Cancer Institute (NCI)
• RECRUITINGNCT07359586
  Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
  Zhejiang University
• RECRUITINGPHASE1NCT07020117
  A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
  Aktis Oncology, Inc.
• RECRUITINGPHASE2NCT06654011
  IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07153952
  RT for Adenocarcinoma/Adenosquamous Carcinoma
  Peking Union Medical College Hospital
• RECRUITINGNCT06733740
  Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
  Chinese PLA General Hospital

See all trials for Adenocarcinoma of the cervix uteri →